133 related articles for article (PubMed ID: 6259)
1. Effect of ergoline derivative VUFB-6638 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Endocrinol Exp; 1975 Jan; 9(1):68-72. PubMed ID: 6259
[TBL] [Abstract][Full Text] [Related]
2. Diminution of prostate by ergoline derivative VUFB--6638 (Dironyl) in rats.
Ausková M; Rezábek K; Marhan O; Zikán V; Semonský M
Endocrinol Exp; 1979 Sep; 13(3):171-6. PubMed ID: 315868
[TBL] [Abstract][Full Text] [Related]
3. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
[TBL] [Abstract][Full Text] [Related]
4. The effect of the ergoline derivative VUFB-6683 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Experientia; 1973 Oct; 29(10):1262-3. PubMed ID: 4796640
[No Abstract] [Full Text] [Related]
5. [Inhibition of lactation by N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea (VUFB-6638)].
Ausková M; Rezábek K; Zikán V; Semonský M
Experientia; 1974 Apr; 30(4):393-4. PubMed ID: 4858213
[No Abstract] [Full Text] [Related]
6. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
[TBL] [Abstract][Full Text] [Related]
8. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Pisarek H; Stepien H; Pawlikowski M
Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
[TBL] [Abstract][Full Text] [Related]
9. Suppression of lactation in rats with lysenylr SPOFA(N-(D-6-methyl-8-isoergolenyl) N', N'-diethylcarbamide hydrogen maleate).
Ausková M; Rezábek K; Zikán V; Semonský M
Endocrinol Exp; 1974 Mar; 8(1):51-8. PubMed ID: 4547705
[No Abstract] [Full Text] [Related]
10. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
11. Induction of oestrus and ovulation with an ergoline derivative, substance VUFB 6638, an inhibitor of prolaction secretion.
Ausková M; Rezábek K; Zikán V; Semonský M
Physiol Bohemoslov; 1974; 23(5):417-21. PubMed ID: 4278534
[No Abstract] [Full Text] [Related]
12. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
[TBL] [Abstract][Full Text] [Related]
14. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines.
Markó M
Eur J Pharmacol; 1984 Jun; 101(3-4):263-6. PubMed ID: 6468500
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prolactin secretion in rats with the ergoline derivative deprenon.
Chlebounová J; Seda M; Fingerová H; Rezábek K
Arzneimittelforschung; 1980; 30(6):956-8. PubMed ID: 7191272
[TBL] [Abstract][Full Text] [Related]
16. Vesicular release of prolactin from preformed prolactin granules is stimulated by soluble factor(s) from the anterior pituitary of lactating rats.
Huerta-Ocampo I; Fiordelisio T; Díaz N; Navarro N; Castilla A; Cárabez A; Aguilar MB; Morales T; Hernández-Cruz A; Mena F
Neuroendocrinology; 2007; 85(1):1-15. PubMed ID: 17341846
[TBL] [Abstract][Full Text] [Related]
17. The effect of 2-bromo-alpha-ergocryptine and 2-chloro-alpha-methylergoline-8beta-acetonitrile (lergotrile mesylate) on the prolactin secretion of the ewe.
Hooley RD; Fell LR; Findlay JK
Acta Endocrinol (Copenh); 1977 Dec; 86(4):722-7. PubMed ID: 411304
[TBL] [Abstract][Full Text] [Related]
18. Relationship between prolactin secretion and hypothalamic prolactin releasing factor in pregnant and puerperium rats.
Takahashi K; Saito M; Wakai T; Hoshiai H; Wada Y
Tohoku J Exp Med; 1976 Nov; 120(3):231-7. PubMed ID: 825991
[TBL] [Abstract][Full Text] [Related]
19. Vinblastine-induced microtubular paracrystals in prolactin cells of anterior pituitary gland of lactating rats.
Shiino M; Rennels EG
Am J Anat; 1975 Nov; 144(3):399-405. PubMed ID: 1211375
[TBL] [Abstract][Full Text] [Related]
20. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
